Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)
China · Delayed Price · Currency is CNY 6.50
-0.17 (-2.55%)
Jan 23, 2026, 3:12 PM CST
SHE:300318 Revenue
Beijing Bohui Innovation Biotechnology Group had revenue of 224.80M CNY in the quarter ending September 30, 2025, with 41.22% growth. This brings the company's revenue in the last twelve months to 834.38M, down -5.76% year-over-year. In the year 2024, Beijing Bohui Innovation Biotechnology Group had annual revenue of 851.69M, down -18.53%.
Revenue (ttm)
834.38M
Revenue Growth
-5.76%
P/S Ratio
6.53
Revenue / Employee
382.92K
Employees
2,179
Market Cap
5.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 851.69M | -193.73M | -18.53% |
| Dec 31, 2023 | 1.05B | 249.50M | 31.35% |
| Jan 1, 2023 | 795.93M | 81.18M | 11.36% |
| Jan 1, 2022 | 714.75M | -23.97M | -3.24% |
| Dec 31, 2020 | 738.72M | 110.38M | 17.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novogene | 2.17B |
| Wuhan Hvsen Biotechnology | 1.67B |
| Hefei Lifeon Pharmaceutical | 1.47B |
| Shenzhen Weiguang Biological Products | 1.14B |
| ChemPartner PharmaTech | 1.07B |
| Lifecome Biochemistry | 587.04M |
| Hangzhou Biotest Biotech | 478.69M |
| Assure Tech (Hangzhou) | 462.72M |